• 0Shopping Cart
AmideBio LLC
  • ABOUT
    • CONTACT
    • NEWS
    • Intellectual Property
  • TEAM
    • Management and Operations
    • Board of Directors
    • Scientific Advisory Board
    • Business Advisory Board
  • SCIENCE
    • Discovery
    • Manufacturing
    • Therapeutic Pipeline
  • PRODUCTS
    • Amyloid Peptides
    • Amyloid Kits and Buffers
    • Bowman-Birk Inhibitors
    • Brazzeins
    • Proinsulin and Insulins
    • Toxins and Knottins
    • Custom Product Inquiry
    • Request Quote
  • NEWS
  • SUPPORT
    • CONTACT
    • Frequently Asked Questions
    • Application Notes
    • Inquiry Form
  • My Account
    • Checkout
    • Login
  • Search
  • Menu

AmideBio CTO Dr. Michael Stowell’s structural work on a potential novel target for Alzheimer’s published in Nature S.R.

You are here: Home / Privacy Policy / NEWS / AmideBio CTO Dr. Michael Stowell’s structural work on a potential novel t...

AmideBio CTO Dr. Michael Stowell’s structural work on a potential novel target for Alzheimer’s published in Nature S.R.

Scroll to top